ZW25883A1 - 4-aminoalkyl-2(3h)-indolones - Google Patents

4-aminoalkyl-2(3h)-indolones

Info

Publication number
ZW25883A1
ZW25883A1 ZW258/83A ZW25883A ZW25883A1 ZW 25883 A1 ZW25883 A1 ZW 25883A1 ZW 258/83 A ZW258/83 A ZW 258/83A ZW 25883 A ZW25883 A ZW 25883A ZW 25883 A1 ZW25883 A1 ZW 25883A1
Authority
ZW
Zimbabwe
Prior art keywords
indolones
aminoalkyl
Prior art date
Application number
ZW258/83A
Other languages
English (en)
Inventor
Gregory Gallagher Jr
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23776840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZW25883(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZW25883A1 publication Critical patent/ZW25883A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZW258/83A 1982-12-07 1983-11-25 4-aminoalkyl-2(3h)-indolones ZW25883A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/447,564 US4452808A (en) 1982-12-07 1982-12-07 4-Aminoalkyl-2(3H)-indolones

Publications (1)

Publication Number Publication Date
ZW25883A1 true ZW25883A1 (en) 1984-04-18

Family

ID=23776840

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW258/83A ZW25883A1 (en) 1982-12-07 1983-11-25 4-aminoalkyl-2(3h)-indolones

Country Status (27)

Country Link
US (1) US4452808A (h)
EP (1) EP0113964B1 (h)
JP (1) JPS59112964A (h)
KR (1) KR910001042B1 (h)
AU (1) AU560170B2 (h)
BR (1) BR1100036A (h)
CA (1) CA1208650A (h)
CY (1) CY1497A (h)
CZ (1) CZ398191A3 (h)
DE (1) DE3367090D1 (h)
DK (1) DK156514C (h)
DZ (1) DZ587A1 (h)
EG (1) EG16556A (h)
ES (2) ES527827A0 (h)
FI (1) FI77849C (h)
GR (1) GR79121B (h)
HK (1) HK82089A (h)
IE (1) IE56347B1 (h)
IL (1) IL70311A (h)
LU (1) LU90097I2 (h)
NL (1) NL970005I2 (h)
NO (2) NO160135C (h)
NZ (1) NZ206344A (h)
PH (1) PH22067A (h)
PT (1) PT77739B (h)
ZA (1) ZA839094B (h)
ZW (1) ZW25883A1 (h)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588740A (en) * 1982-12-07 1986-05-13 Smithkline Beckman Corporation Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8621040D0 (en) * 1986-08-30 1986-10-08 Smith Kline French Lab Process
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
PT923551E (pt) * 1996-08-27 2002-09-30 American Home Prod Derivados de 4-aminoetoxi indolona
EP1073636A1 (en) * 1998-04-13 2001-02-07 American Home Products Corporation 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) * 2000-07-17 2001-08-21 Andrew J. Holman Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
DK1545546T3 (da) * 2002-09-13 2007-08-06 Motac Neuroscience Ltd Behandling af dyskinesi med 2,3-benzodiazepiner
ATE360415T1 (de) * 2002-09-17 2007-05-15 Motac Neuroscience Ltd Behandlung von dyskinesie
ES2237307B1 (es) * 2003-10-14 2006-11-01 Urquima, S.A. Procedimiento para la preparacion de ropinirol.
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
ES2317241T3 (es) * 2004-05-11 2009-04-16 Egis Gyogyszergyar Nyrt Derivados de piperazina de alquil oxindoles.
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
US20080214622A1 (en) * 2005-03-21 2008-09-04 Alan Daniel Brown Substituted Triazole Derivatives As Oxytocin Antagonists
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法
WO2007010557A2 (en) * 2005-07-22 2007-01-25 Ind-Swift Laboratorie Limted Process for the preparation of highly pure ropinirole
CA2645599A1 (en) 2006-03-29 2007-10-04 Alembic Limited A process for the purification of ropinirole hydrochloride
SI2010184T1 (sl) * 2006-04-06 2013-05-31 Nupathe Inc. Implantati za zdravljenje stanj, povezanih z dopaminom
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN100457732C (zh) * 2006-05-25 2009-02-04 药源药物化学（上海）有限公司 罗匹尼罗的制备方法
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
ATE535243T1 (de) * 2007-05-11 2011-12-15 Santen Pharmaceutical Co Ltd Prophylaktisches oder therapeutisches mittel für posteriore augenerkrankung mit selektivem nicht- ergot-d2-rezeptoragonist als wirkstoff
US20090076124A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched ropinirole
US20090247537A1 (en) * 2008-03-25 2009-10-01 William Dale Overfield Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) * 2008-05-05 2012-12-19 北京德众万全医药科技有限公司 一种罗匹尼罗的口服固体药物组合物
WO2010023693A2 (en) * 2008-09-01 2010-03-04 Lupin Limited Novel controlled release compositions of ropinirole
WO2010035245A2 (en) 2008-09-29 2010-04-01 Wockhardt Research Centre Extended release dosage form of ropinirole
WO2010060070A2 (en) * 2008-11-24 2010-05-27 Auspex Pharmaceuticals, Inc. Indolinone modulators of dopamine receptor
JP5514815B2 (ja) 2009-05-21 2014-06-04 久光製薬株式会社 経皮吸収製剤
US20120253051A1 (en) * 2009-12-16 2012-10-04 Pharmathen S.A. Process for the preparation of ropinirole and salts thereof
US9017723B2 (en) 2010-04-30 2015-04-28 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
EP2688561B1 (en) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
MX366649B (es) 2012-11-02 2019-07-17 Teikoku Seiyaku Kk Composiciones transdérmicas de propinilaminoindan.
WO2014092006A1 (ja) 2012-12-10 2014-06-19 キッセイ薬品工業株式会社 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
EP3640240B1 (en) 2017-06-16 2020-12-09 Zhejiang Huahai Licheng Pharmaceutical Co., Ltd. Method for purifying ropinirole hydrochloride
CN115466209A (zh) * 2022-09-29 2022-12-13 南通大学 一种罗匹尼罗环戊烷并吲哚酮杂质的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA895875A (en) * 1972-03-21 Bourdais Jacques Mercapto indole derivatives
US3573310A (en) * 1967-09-28 1971-03-30 Miles Lab 1-substituted derivatives of 2-indolinone
JPS5825673B2 (ja) * 1976-03-31 1983-05-28 大塚製薬株式会社 オキシインド−ル誘導体
JPS5840539B2 (ja) * 1976-03-31 1983-09-06 大塚製薬株式会社 α−置換アミノアルカノイルオキシインド−ル誘導体
JPS5919537B2 (ja) * 1976-08-02 1984-05-07 大塚製薬株式会社 オキシインド−ル誘導体
US4317944A (en) * 1980-08-15 1982-03-02 General Electric Company Preparation of 2,2-bis(4-hydroxyphenyl) propane
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
NO160135C (no) 1989-03-15
IE56347B1 (en) 1991-07-03
FI77849C (fi) 1989-05-10
ES8604143A1 (es) 1986-01-16
PT77739A (en) 1983-12-01
IE832866L (en) 1984-06-07
JPS59112964A (ja) 1984-06-29
DE3367090D1 (de) 1986-11-27
ES543593A0 (es) 1986-01-16
DK562183A (da) 1984-06-08
NO834485L (no) 1984-06-08
ZA839094B (en) 1985-02-27
DK156514B (da) 1989-09-04
PT77739B (en) 1986-03-27
CA1208650A (en) 1986-07-29
BR1100036A (pt) 2000-01-11
NL970005I1 (nl) 1997-04-01
PH22067A (en) 1988-05-20
GR79121B (h) 1984-10-02
KR840006963A (ko) 1984-12-04
US4452808A (en) 1984-06-05
DZ587A1 (fr) 2004-09-13
NO1999011I1 (no) 1999-06-18
FI77849B (fi) 1989-01-31
IL70311A0 (en) 1984-02-29
KR910001042B1 (ko) 1991-02-21
HK82089A (en) 1989-10-20
ES8600239A1 (es) 1985-10-01
EP0113964A1 (en) 1984-07-25
CZ398191A3 (en) 1993-02-17
FI834421L (fi) 1984-06-08
FI834421A0 (fi) 1983-12-02
AU2158583A (en) 1984-06-14
JPH0150703B2 (h) 1989-10-31
NL970005I2 (nl) 1997-10-01
EP0113964B1 (en) 1986-10-22
LU90097I2 (fr) 1997-07-16
NO160135B (no) 1988-12-05
NZ206344A (en) 1987-03-31
DK156514C (da) 1990-03-12
DK562183D0 (da) 1983-12-06
ES527827A0 (es) 1985-10-01
AU560170B2 (en) 1987-04-02
CY1497A (en) 1990-02-16
IL70311A (en) 1986-11-30
EG16556A (en) 1989-01-30

Similar Documents

Publication Publication Date Title
IL70311A0 (en) 4-aminoalkyl-2(3h)-indolones
CS124683A2 (en) Zpusob zapouzdreni ucinne latky chemickeho prostredku
CS503683A2 (en) Zpusob vyroby (s)-epimeru esteru kyseliny 7beta-malonamido-7alfa-methoxy-3-tetrazolylthiomethyl-1-dethia-1-oxa-3-cefem-4-karboxylove
AR242637A1 (es) Zurradera (maquina de zurrar) para el procesamiento de cueros y pieles.
GB2127809B (en) Certain b-oxo-a-carbamoyl-pyrrolepropionitriles
IL68967A0 (en) Can
MY8600569A (en) Ergotalkaloids
CS130683A1 (en) Mezihridelove radialne celni kontaktni tesneni
CS1010682A1 (en) Samosvorny hydraulicky obvod
CS102482A1 (en) Stabilizacni zarizeni plasmoveho generatoru
CA50080S (en) Bruach
CS151782A1 (en) Odstredivy odlucovac
AU87491S (en) Rangehood
AU87355S (en) Phoneclip
AU87024S (en) Watch-pen
CS12382A1 (en) Spektrofluorometr
CS119282A1 (en) Zapojeni nahonu prumysloveho siciho stroje
CS151482A1 (en) Rohova dverni zaruben
AU87492S (en) Rangehood
CS11382A1 (en) Abrazivna guma
CS156182A1 (en) Stabilizovany zdroj sinusoveho prudu
BG45685A1 (en) Rc- generator
CS475582A1 (en) Odlucovac kvapiek
CS1001482A1 (en) Vpichovana netkana textilie
CS112782A1 (en) Sestavovaci montazni kufr